This web publication constitutes a notice for the purposes of regulation 42ZCZS of the Therapeutic Goods Regulations 1990 (the Regulations). In accordance with regulations 42ZCZS, this notice publishes the:
- decisions made by a delegate of the Secretary pursuant to regulations 42ZCZR;
- reasons for those final decisions; and
- date of effect of those decisions.
Final decision in relation to cannabis and THCs
Note that the final decision for cannabis and tetrahydrocannabinols is not published in this notice. This decision has been delayed, pending further consultation with relevant stakeholders, and will be published following review of the consultation.
Final decisions and reasons
- Notice of final decisions - ACMS #36, Joint ACMS-ACCS #29, ACCS #32, November 2021 meetings (pdf,242kb)
- Notice of final decisions - ACMS #36, Joint ACMS-ACCS #29, ACCS #32, November 2021 meetings (docx,103kb)
We aim to provide documents in an accessible format. If you're having problems using this document, please contact medicines.scheduling@health.gov.au.
Contents
- 1 Notice of Decisions to amend the current Poisons Standard
- 2 Final decisions on proposed amendments referred to the Advisory Committee on Medicines Scheduling (ACMS #36, November 2021)
- 2.1 Final decision in relation to astodrimer sodium
- 2.2 Final decision in relation to flurbiprofen
- 3 Final decisions on proposed amendments referred to the Advisory Committee on Medicines and Chemicals Scheduling in joint session (Joint ACMS-ACCS #29, November 2021)
- 3.1 Final decision in relation to cis-jasmone
- 3.2 Final decision in relation to meloxicam
- 3.3 Final decision in relation to choline salicylate
- 4 Final decisions on proposed amendments referred to the Advisory Committee on Chemicals Scheduling (ACCS #32, November 2021)
- 4.1 Final decision in relation to chromates and chromium trioxide